ST PHI THERAPEUTICS
Yizun Biotechnology is a cutting-edge immune cell therapy company that has developed many unique platform technologies, including solid tumor treatment and allogeneic universal cell therapy.
ST PHI THERAPEUTICS
Industry:
Biotechnology Hospital Medical
Founded:
2017-01-01
Address:
Shanghai, Shanghai, China
Country:
China
Website Url:
http://www.stphitherapeutics.com
Status:
Active
Contact:
7364541699
Email Addresses:
[email protected]
Total Funding:
100 M CNY
Investors List
Tailong Investment
Tailong Investment investment in Series A - St Phi Therapeutics
Mr. Zheng Xiaodong
Mr. Zheng Xiaodong investment in Series A - St Phi Therapeutics
Hangzhou Binjiang 5050 Fund
Hangzhou Binjiang 5050 Fund investment in Series A - St Phi Therapeutics
Taiyu Investment
Taiyu Investment investment in Series A - St Phi Therapeutics
Teda Venture Capital
Teda Venture Capital investment in Series A - St Phi Therapeutics
Shenzhen Capital Group
Shenzhen Capital Group investment in Series A - St Phi Therapeutics
VMS Capital
VMS Capital investment in Series A - St Phi Therapeutics
Tao Capital Partners
Tao Capital Partners investment in Series A - St Phi Therapeutics
Tasly Capital
Tasly Capital investment in Series A - St Phi Therapeutics
Panacea Venture
Panacea Venture investment in Series A - St Phi Therapeutics
Official Site Inspections
http://www.stphitherapeutics.com
- Host name: 47.94.141.202
- IP address: 47.94.141.202
- Location: Hangzhou China
- Latitude: 30.294
- Longitude: 120.1619
- Timezone: Asia/Shanghai
More informations about "St Phi Therapeutics"
羿尊生物
羿尊生物是一家具有多项独创性平台技术的免疫细胞治疗新锐企业，以治疗实体肿瘤和异体通用型细胞技术为特色See details»
St Phi Therapeutics - Crunchbase Company Profile
CNK-UT: A universal cell technology integrating CNK-T and U-T platforms, designed to target and treat various solid and blood tumors by modifying T …See details»
ST Phi Therapeutics - CoMotion
The mission of the company is to develop innovative diagnostic reagents, cellular therapeutics technologies and engineered cell products to help cure human diseases, including cancer, autoimmune disease, virus-infection diseases and …See details»
About_Us - en.stphibio.com
Demonstrated long-term safety and efficacy in liver cancer, neuroblastoma and breast cancer patients Demonstrated long-term safety and efficacy in treating steroid refractory graft-versus …See details»
ST Phi Therapeutics 2025 Company Profile: Valuation, Funding ...
Jan 8, 2018 Deal Type Date Amount Raised to Date Post-Val Status Stage; 2. Out of Business: 03-Apr-2020: Completed: Out of Business: 1. Angel (individual) 08-Jan-2018: CompletedSee details»
ST Phi - Products, Competitors, Financials, Employees, …
Headquarters Location. No. 658, Bin'an Road, Binjiang District, Room 208, 2nd Floor, Building 1/2. Hangzhou, Zhejiang , 310051, China. 17364541699See details»
ST Phi Therapeutics Co., Ltd. - Drug pipelines, Patents, …
Explore ST Phi Therapeutics Co., Ltd. with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, and 2 literature, Disease Domain:Neoplasms, Endocrinology and Metabolic Disease, Hemic and Lymphatic Diseases, …See details»
羿尊生物（ST Phi）完成近亿元A+轮融资 - 创投之家
Apr 15, 2024 羿尊生物医药（浙江）有限公司（羿尊生物，ST Phi）完成近亿元 A+ 轮融资，本轮融资由泰珑投资和泰煜投资联合领投，东富龙董事长郑效东先生、杭州滨江5050基金跟投， …See details»
ST Global Health
To produce exceptional returns and catalyze global health. We do this by investing in listed healthcare companies leveraging disruptive technology and service models that enhance access to the highest quality of care for the …See details»
Patents Assigned to ST PHI THERAPEUTICS CO., LTD.
Mar 9, 2020 Abstract: The invention discloses chimeric endocytic receptor CER-based constructs for activating and regulating immune response, and method for using the same. …See details»
Phi Therapeutics, Inc. Company Profile | San Francisco, CA ...
Find company research, competitor information, contact details & financial data for Phi Therapeutics, Inc. of San Francisco, CA. Get the latest business insights from Dun & Bradstreet.See details»
Our Team – Phi Pharma
Peter Greaney, PhD. is a global deal-maker and is passionate about advancing innovative science for the benefit of patients. Peter has international experience in building successful …See details»
域名stphitherapeutics.com的Whois信息 - ICP备案查询网
所有者： 所有者联系邮箱： 注册商： Alibaba Cloud Computing (Beijing) Co., Ltd. 注册日期： 2017-08-14: 到期时间：See details»
St Phi Therapeutics - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Apr 15, 2024: Series A - St Phi …See details»
ST Phi Therapeutics - Products, Competitors, Financials, Employees ...
Headquarters Location. 1100 NE Campus Parkway Suite 200. Seattle, Washington, 98195, United StatesSee details»
stphitherapeutics.com的WHOIS信息_stphitherapeutics.com注册信 …
Jul 14, 2023 在线工具网提供stphitherapeutics.com的WHOIS信息查询、stphitherapeutics.com注册信息查询功能，输入域名号即可查询全球1300多种顶级域名的WHOIS信息，包括如注册时 …See details»
API – Life Sciences Applied
About us. We empower commercial development in the Canadian life sciences industry. Based in Edmonton with a satellite location in Calgary, API works to build and support the life sciences …See details»
Find Therapeutics – Finding hope by expanding the frontiers of …
Sep 16, 2024 We design ground-breaking therapies through precision-targeting of membrane receptors to bring hope to people living with autoimmune diseasesSee details»
Home - Appili Therapeutics
Appili Therapeutics is a people-focused biopharmaceutical company focused on tackling the serious global challenges in infectious disease and biodefense.See details»
St Phi Therapeutics - Tech Stack, Apps, Patents & Trademarks
Mar 10, 2025 Organization. St Phi Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Highlights. Active Tech Count 4. Monthly …See details»